Janel M. Boyce-Rustay - Publications

Affiliations: 
Abbott Laboratories, Irving, TX, United States 
Area:
Behavioral Pharmacology

12/21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Boyce-Rustay JM, Simler GH, McGaraughty S, Chu KL, Wensink EJ, Vasudevan A, Honore P. Characterization of Fasudil in preclinical models of pain. The Journal of Pain : Official Journal of the American Pain Society. 11: 941-9. PMID 20338818 DOI: 10.1016/j.jpain.2009.12.014  0.303
2008 Boyce-Rustay JM, Palachick B, Hefner K, Chen YC, Karlsson RM, Millstein RA, Harvey-White J, Holmes A. Desipramine potentiation of the acute depressant effects of ethanol: modulation by alpha2-adrenoreceptors and stress. Neuropharmacology. 55: 803-11. PMID 18625256 DOI: 10.1016/J.Neuropharm.2008.06.032  0.436
2008 Boyce-Rustay JM, Janos AL, Holmes A. Effects of chronic swim stress on EtOH-related behaviors in C57BL/6J, DBA/2J and BALB/cByJ mice. Behavioural Brain Research. 186: 133-7. PMID 17822784 DOI: 10.1016/j.bbr.2007.07.031  0.378
2007 Boyce-Rustay JM, Cameron HA, Holmes A. Chronic swim stress alters sensitivity to acute behavioral effects of ethanol in mice. Physiology & Behavior. 91: 77-86. PMID 17363014 DOI: 10.1016/J.Physbeh.2007.01.024  0.483
2007 Carroll JC, Boyce-Rustay JM, Millstein R, Yang R, Wiedholz LM, Murphy DL, Holmes A. Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behavior Genetics. 37: 214-22. PMID 17177116 DOI: 10.1007/S10519-006-9129-9  0.346
2006 Boyce-Rustay JM, Wiedholz LM, Millstein RA, Carroll J, Murphy DL, Daws LC, Holmes A. Ethanol-related behaviors in serotonin transporter knockout mice. Alcoholism, Clinical and Experimental Research. 30: 1957-65. PMID 17117959 DOI: 10.1111/J.1530-0277.2006.00241.X  0.481
2006 Boyce-Rustay JM, Holmes A. Ethanol-related behaviors in mice lacking the NMDA receptor NR2A subunit. Psychopharmacology. 187: 455-66. PMID 16835771 DOI: 10.1007/s00213-006-0448-6  0.566
2006 Daws LC, Montañez S, Munn JL, Owens WA, Baganz NL, Boyce-Rustay JM, Millstein RA, Wiedholz LM, Murphy DL, Holmes A. Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 6431-8. PMID 16775130 DOI: 10.1523/Jneurosci.4050-05.2006  0.471
2006 Boyce-Rustay JM, Holmes A. Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2405-14. PMID 16482087 DOI: 10.1038/sj.npp.1301039  0.401
2005 Boyce-Rustay JM, Holmes A. Functional roles of NMDA receptor NR2A and NR2B subunits in the acute intoxicating effects of ethanol in mice. Synapse (New York, N.Y.). 56: 222-5. PMID 15803501 DOI: 10.1002/syn.20143  0.555
2004 Boyce-Rustay JM, Cunningham CL. The role of NMDA receptor binding sites in ethanol place conditioning. Behavioral Neuroscience. 118: 822-34. PMID 15301608 DOI: 10.1037/0735-7044.118.4.822  0.571
2003 Boyce-Rustay JM, Risinger FO. Dopamine D3 receptor knockout mice and the motivational effects of ethanol. Pharmacology, Biochemistry, and Behavior. 75: 373-9. PMID 12873629 DOI: 10.1016/S0091-3057(03)00091-1  0.532
Low-probability matches (unlikely to be authored by this person)
2010 Boyce-Rustay JM, Zhong C, Kohnken R, Baker SJ, Simler GH, Wensink EJ, Decker MW, Honore P. Comparison of mechanical allodynia and the affective component of inflammatory pain in rats. Neuropharmacology. 58: 537-43. PMID 19703478 DOI: 10.1016/j.neuropharm.2009.08.008  0.294
2010 Boyce-Rustay JM, Honore P, Jarvis MF. Animal models of acute and chronic inflammatory and nociceptive pain. Methods in Molecular Biology (Clifton, N.J.). 617: 41-55. PMID 20336412 DOI: 10.1007/978-1-60327-323-7_4  0.283
2009 Jarvis MF, Boyce-Rustay JM. Neuropathic pain: models and mechanisms. Current Pharmaceutical Design. 15: 1711-6. PMID 19442185 DOI: 10.2174/138161209788186272  0.27
2012 Scott VE, Vortherms TA, Niforatos W, Swensen AM, Neelands T, Milicic I, Banfor PN, King A, Zhong C, Simler G, Zhan C, Bratcher N, Boyce-Rustay JM, Zhu CZ, Bhatia P, et al. A-1048400 is a novel, orally active, state-dependent neuronal calcium channel blocker that produces dose-dependent antinociception without altering hemodynamic function in rats. Biochemical Pharmacology. 83: 406-18. PMID 22153861 DOI: 10.1016/j.bcp.2011.10.019  0.257
2013 Hudzik TJ, Basso A, Boyce-Rustay JM, Bracken W, Browman KE, Drescher K, Esbenshade TA, Loberg LI, Lynch JJ, Brioni JD. Assessment of the abuse liability of ABT-288, a novel histamine H₃ receptor antagonist. Psychopharmacology. 228: 187-97. PMID 23455597 DOI: 10.1007/s00213-013-3027-7  0.256
2012 Beebe X, Darczak D, Henry RF, Vortherms T, Janis R, Namovic M, Donnelly-Roberts D, Kage KL, Surowy C, Milicic I, Niforatos W, Swensen A, Marsh KC, Wetter JM, Franklin P, ... ... Boyce-Rustay JM, et al. Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca²⁺ channel blockers with analgesic activity. Bioorganic & Medicinal Chemistry. 20: 4128-39. PMID 22626552 DOI: 10.1016/j.bmc.2012.04.057  0.23
2019 Rothenberg ME, Tagen M, Chang JH, Boyce-Rustay J, Friesenhahn M, Hackos DH, Hains A, Sutherlin D, Ward M, Cho W. Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel Na1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers. Clinical Drug Investigation. PMID 31172446 DOI: 10.1007/S40261-019-00807-3  0.137
2014 Ratcliffe SL, Chappell PB, Boyce-Rustay J, Gloukhova S, Oleske DM. Treatment emergent suicidal ideation and behavior Suicide: Phenomenology and Neurobiology. 31-58. DOI: 10.1007/978-3-319-09964-4_3  0.062
2019 Rothenberg ME, Tagen M, Chang JH, Boyce-Rustay J, Friesenhahn M, Hackos DH, Hains A, Sutherlin D, Ward M, Cho W. Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel Na1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers. Clinical Drug Investigation. PMID 31338799 DOI: 10.1007/s40261-019-00832-2  0.028
Hide low-probability matches.